Trials / Active Not Recruiting
Active Not RecruitingNCT04967170
A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus
A Pilot, Randomized, Blinded, Controlled Study Evaluating Autologous Platelet-Rich Plasma for the Treatment of Vulvar Lichen Sclerosus
- Status
- Active Not Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Jennifer R. Arthurs · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purposes of this study are to determine the safety and feasibility of autologous platelet-rich plasma for the treatment of vulvar lichen sclerosus, and to determine the efficacy of autologous platelet-rich plasma for the treatment of vulvar lichen sclerosus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Autologous Platelet-Rich Plasma (PRP) | Two intralesional injections of approximately 5-6mL given approximately 6 weeks apart |
| OTHER | Sham Procedure | Intralesional needle insertion without any injectate. |
Timeline
- Start date
- 2022-01-19
- Primary completion
- 2026-06-01
- Completion
- 2026-06-02
- First posted
- 2021-07-19
- Last updated
- 2026-02-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04967170. Inclusion in this directory is not an endorsement.